Gross Margin
7.47%vs Specialty Chemicals peers Updated Nov 19, 2026Profit Margin
-0.53%vs Specialty Chemicals peers Updated Nov 19, 2026Operating Margin
-2.83%vs Specialty Chemicals peers Updated Nov 19, 2026Return on Assets (TTM)
-0.92%vs Specialty Chemicals peers Updated Nov 19, 2026Return on Equity (TTM)
-0.46%vs Specialty Chemicals peers Updated Nov 19, 2026Revenue (TTM)
2.40BCNY359.89M · vs all stocks (USD) Updated Nov 19, 2026Revenue per Share (TTM)
2.60CNYUpdated Nov 19, 2026Quarterly Revenue Growth
14.90%vs Specialty Chemicals peers Updated Nov 19, 2026Gross Profit (TTM)
155.78MCNY23.37M · vs all stocks (USD) Updated Nov 19, 2026EBITDA (TTM)
77.75MCNY11.66M · vs all stocks (USD) Updated Nov 19, 2026Net Income (TTM)
-12.62MCNY-1.89M · vs all stocks (USD) Updated Nov 19, 2026Quarterly Earnings Growth (YoY)
30.51%vs Specialty Chemicals peers Updated Nov 19, 2026Operating Cash Flow (TTM)
179.22MCNY26.88M · vs all stocks (USD) Updated Nov 19, 2026Levered Free Cash Flow (TTM)
-271.60MCNY-40.74M · vs all stocks (USD) Updated Nov 19, 20265-Year Average Dividend Yield
0.38%Updated Nov 19, 2026Payout Ratio
48.19%vs Specialty Chemicals peers Updated Nov 19, 2026Revenue
2.17BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
2.05BCNYFY2025 · Dec 31, 2025Gross Profit
118.56MCNYFY2025 · Dec 31, 2025Operating Income
-85.63MCNY-12.84M · vs all stocks (USD) FY2025 · Dec 31, 2025Pre-tax Income
-71.37MCNYFY2025 · Dec 31, 2025Income Tax Expense
1.09MCNYFY2025 · Dec 31, 2025Net Income
-72.47MCNYFY2025 · Dec 31, 2025EBIT
-65.72MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
77.75MCNYFY2025 · Dec 31, 2025Research & Development
90.81MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
30.04MCNYFY2025 · Dec 31, 2025Other Operating Expenses
13.91MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
4.00MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
5.65MCNYFY2025 · Dec 31, 2025EPS (Basic)
-0.0800CNYFY2025 · Dec 31, 2025EPS (Diluted)
-0.0800CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
905.84MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
905.84MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-72.47MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
6.44MCNYFY2025 · Dec 31, 2025Free Cash Flow
-800.25MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
214.88MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-72.47MCNYFY2025 · Dec 31, 2025Other Non-cash Items
11.32MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
86.23MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-18.65MCNYFY2025 · Dec 31, 2025Capital Expenditures
-806.69MCNYFY2025 · Dec 31, 2025Sale of Investments
18.37MCNYFY2025 · Dec 31, 2025Other Investing Activity
130.00MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-658.32MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
766.95MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-289.63MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-19.03MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
458.29MCNYFY2025 · Dec 31, 2025